Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention of relapse in ulcerative colitis
NCT03122613Terminated
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2017
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial in ulcerative colitis (UC) comparing Curcumin Arm with Placebo Arm (2 arms). Primary endpoint: Relapse rate at 12 months. Started Jun 2017; status: terminated.
02
Drugs
curcumin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03122613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122613.